Benzinga | Aug 11, 2021 07:10AM EDT

Evogene Q2 Sales $135.00K Miss $300.00K Estimate

Evogene (NASDAQ:EVGN) reported quarterly sales of $135.00 thousand which missed the analyst consensus estimate of $300.00 thousand by 55.00 percent. This is a 54.70 percent decrease over sales of $298.00 thousand the same period last year.